Timothy S. Shilton
Chief Executive Officer at ReGen Therapeutics Ltd.
Timothy S. Shilton active positions
Companies | Position | Start | End |
---|---|---|---|
Phairson Medical Ltd.
Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | Sales & Marketing | 2010-11-09 | - |
ReGen Therapeutics Ltd.
ReGen Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Ltd. manufactures and distributes pharmaceutical products. The company was founded in February 1998 and is headquartered in in London, the United Kingdom. | Director/Board Member | 2011-01-31 | - |
Chief Executive Officer | 2011-01-31 | - |
Career history of Timothy S. Shilton
Former positions of Timothy S. Shilton
Companies | Position | Start | End |
---|---|---|---|
ReGen Therapeutics Plc
ReGen Therapeutics Plc Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Plc develops healthcare nutraceutical and ethical pharmaceuticals. Its principal activity is research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. It also involves in the development of Colostrinin peptides as pharmaceutical drug candidates for the treatment of Alzheimer's disease and obesity. ReGen Therapeutics Plc conducts pharmacokinetic and pharmacodynamic research. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 2009-08-11 | 2011-02-22 |
Alexander David Investments Plc
Alexander David Investments Plc Financial ConglomeratesFinance Alexander David Investments Plc operates as an investment company. Its investment targets are small cap and special opportunities with a current bias towards basic resources and oil and gas sectors. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Director/Board Member | 2011-02-09 | 2011-02-09 |
Training of Timothy S. Shilton
University of Surrey | Undergraduate Degree |
Statistics
International
United Kingdom | 6 |
Operational
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 4 |
---|---|
ReGen Therapeutics Plc
ReGen Therapeutics Plc Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Plc develops healthcare nutraceutical and ethical pharmaceuticals. Its principal activity is research and development of a drug product called Colostrinin for the treatment for Alzheimer's disease and other neurological disorders. It also involves in the development of Colostrinin peptides as pharmaceutical drug candidates for the treatment of Alzheimer's disease and obesity. ReGen Therapeutics Plc conducts pharmacokinetic and pharmacodynamic research. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Health Technology |
Phairson Medical Ltd.
Phairson Medical Ltd. Miscellaneous Commercial ServicesCommercial Services Phairson Medical Ltd. researches and develops novel biopharmaceutical products and devices. The private company is based in London, UK. | Commercial Services |
Alexander David Investments Plc
Alexander David Investments Plc Financial ConglomeratesFinance Alexander David Investments Plc operates as an investment company. Its investment targets are small cap and special opportunities with a current bias towards basic resources and oil and gas sectors. The company was founded on February 11, 1998 and is headquartered in London, the United Kingdom. | Finance |
ReGen Therapeutics Ltd.
ReGen Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology ReGen Therapeutics Ltd. manufactures and distributes pharmaceutical products. The company was founded in February 1998 and is headquartered in in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Timothy S. Shilton
- Experience